Roflumilast Cream 0.3% in Patients with Chronic Plaque Psoriasis: Individual Patient Response from the Pooled DERMIS-1 and DERMIS-2 Phase 3 Trials. (2024). SKIN The Journal of Cutaneous Medicine, 8(1), s310. https://doi.org/10.25251/skin.8.supp.310